Richard Peters

Richard Peters was the founder of MedNav, Inc. (1997), serving as Chief Executive Officer from 1997 to 2003.
Dr. Peters was the founder of PIC Therapeutics, Inc. (2016), serving as Director from 2016 to 2022.
Dr. Peters is the founder of Tellbio, Inc. (2019), serving as Executive Chairman since 2019.
Dr. Peters is the founder of X4 Pharmaceuticals, Inc. with founding dates listed as 2010 and 2014, with no titles specified.
Dr. Peters is currently President, Chief Executive Officer & Director at Yumanity, Inc. Dr. Peters is Chairman at Pharming Group NV since 2023.
Dr. Peters is Chairman at Aprea Therapeutics, Inc. since 2023.
Dr. Peters was President, Chief Executive Officer & Director at Merrimack Pharmaceuticals, Inc. from 2017 to 2019.
Dr. Peters was President, CEO, Secretary, Treasurer & Director at Yumanity Therapeutics, Inc. from 2020 to 2022.
Dr. Peters was Director-Medical Affairs at Amgen, Inc. from 2003 to 2006.
Dr. Peters was Senior Director at Onyx Pharmaceuticals, Inc. from 2006 to 2008.
Dr. Peters was Lead Independent Director at Kineta, Inc. from 2022 to 2025.
Dr. Peters was Senior Vice President & Head-Global Rare Diseases at Genzyme Corp.
from 2008 to 2017.
Dr. Peters earned a doctorate from The Medical University of South Carolina.
Dr. Peters completed undergraduate studies at the College of Charleston.